In a strategic move to bolster its capabilities in temperature-sensitive and time-critical logistics across Europe, UPS has announced the acquisition of Frigo-Trans and its sister company BPL, leading healthcare logistics providers in Germany. The acquisition aims to address the growing demand within the pharmaceutical industry for advanced cold and frozen supply chains. Kate Gutmann, UPS Executive Vice President and President of International, Healthcare, and Supply Chain Solutions, highlighted that this acquisition is set to expand UPS’s portfolio and support its ambition to become the premier provider of complex healthcare logistics worldwide.
Frigo-Trans brings to the table extensive temperature-controlled warehousing that covers six temperature zones, ranging from cryopreservation (-196°C) to ambient conditions (+15° to +25°C). Alongside this, Frigo-Trans offers Pan-European cold chain transportation and temperature-controlled freight forwarding. The transaction is expected to close in the first quarter of 2025, pending regulatory reviews and approvals. Despite the financial terms of the deal remaining undisclosed, the acquisition signifies a significant investment by UPS in healthcare logistics.
Meeting Growing Demands in Pharmaceutical Logistics
UPS has strategically acquired Frigo-Trans and its sister company BPL to strengthen its capabilities in temperature-sensitive and time-critical logistics across Europe. Both companies are leading healthcare logistics providers in Germany. This acquisition is set to meet the growing demand in the pharmaceutical industry for advanced cold and frozen supply chains. Kate Gutmann, UPS Executive Vice President and President of International, Healthcare, and Supply Chain Solutions, emphasized that this move will broaden UPS’s portfolio and support its goal of becoming the leading provider of complex healthcare logistics globally.
Frigo-Trans offers extensive temperature-controlled warehousing spanning six different temperature zones, from cryopreservation at -196°C to ambient conditions between +15° and +25°C. Additionally, Frigo-Trans provides Pan-European cold chain transportation and temperature-controlled freight forwarding. The acquisition is anticipated to close in the first quarter of 2025, subject to regulatory approvals. Despite undisclosed financial details, this significant investment underscores UPS’s commitment to healthcare logistics.
